Taiwan-based Instant NanoBiosensors (INB) is a pioneer that specializes in light-sensing biosensor platform development. The mission of the company’s dynamic and problem-driven R&D team is to advance biomedical research and improve patient care by providing customers with simple, reliable, and cost-effective solutions. Its state-of-the-art fiberoptic particle plasmon resonance (FOPPR) technology offers instant and accurate results for a wide range of detection applications. By combining novel biomarkers with a cutting-edge biosensing platform, INB aspires to revolutionize traditional immunoassays and analyses for a more efficient healthcare ecosystem.